The fact that the “children’s” version of “Sputnik” has received registration from the Ministry of Health, said the deputy head of the Gamaleya Center Denis Logunov
A vaccine developed in Russia designed to protect adolescents aged 12-17 against coronavirus infection COVID-19 has received registration from the Ministry of Health. This was stated by Denis Logunov, deputy head of the Gamaleya Research Center for Epidemiology and Microbiology.
“Today, permission has been received to use Sputnik in the children’s population, the vaccine has received registration, we can share this joyful fact,” Logunov said.
The vaccine has not yet been mentioned in the State Register of Medicines.
Earlier Wednesday about the upcoming vaccine registration reported Deputy Prime Minister Tatyana Golikova at a meeting with Russian President Vladimir Putin.
“Today, the Ministry of Health will register the Gam-COVID-Vac-M vaccine of the Gamaleya Center for children aged 12 to 17 years,” she said, noting that vaccinations with the new drug will be given to children under 15 only with the consent of one from the parents, and the rest – with their own consent.